Grant/GrossMendelsohn, LLC
- SEC CIK
- 0001810677
- Latest filing
- May 1, 2025
TARS holding history
Tarsus Pharmaceuticals, Inc. in every 13F filed by Grant/GrossMendelsohn, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TARS overviewAll 13F holders of TARSFull Q1 2025 holdings
- Shares (Q1 2025)
- 13,156
- Value
- $654.1K
- % of portfolio
- 0.4%
- Quarters held
- 8
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 13,156 | $654.1K | 0.4% | −26,143−66.5% | Reduced | Holders |
| Q4 2024 | 39,299 | $2.18M | 1.1% | −14,331−26.7% | Reduced | Holders |
| Q3 2024 | 53,630 | $1.76M | 0.8% | +30+0.1% | Added | Holders |
| Q2 2024 | 53,600 | $1.46M | 0.7% | −100.0% | Reduced | Holders |
| Q1 2024 | 53,610 | $1.94M | 0.9% | 00.0% | Unchanged | Holders |
| Q4 2023 | 53,610 | $1.38M | 0.6% | 00.0% | Unchanged | Holders |
| Q3 2023 | 53,610 | $952.6K | 0.4% | −150.0% | Reduced | Holders |
| Q2 2023 | 53,625 | $939.0K | 0.4% | +53,625 | New | Holders |